BioGaia AB ser. B (BIOGb)

Currency in SEK
112.7
+4.7(+4.35%)
Closed·
High dividend Yield
BIOGb is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
108.7113.5
52 wk Range
93.2139.7
Key Statistics
Prev. Close
108
Open
108.7
Day's Range
108.7-113.5
52 wk Range
93.2-139.7
Volume
463.83K
Average Volume (3m)
289.26K
1-Year Change
-3.4276%
Book Value / Share
12.04
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BIOGb Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
140.0
Upside
+24.22%
Members' Sentiments
Bearish
Bullish
ProTips
Pays a significant dividend to shareholders

BioGaia AB ser. B News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

BioGaia AB ser. B Company Profile

BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula and milk formula. The Adult Health segment provides gut health tablets, bone health tablets and oral health lozenges, as well as cultures, which are used as an ingredient in a licensee’s dairy product. The Other segment provides packaging solutions. It sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was incorporated in 1990 and is based in Stockholm, Sweden.

Employees
238
Market
Sweden

Compare BIOGb to Peers and Sector

Metrics to compare
BIOGb
Peers
Sector
Relationship
P/E Ratio
UnlockNaNNaNUnlock
PEG Ratio
UnlockNaNNaNUnlock
Price/Book
UnlockNaNNaNUnlock
Price / LTM Sales
UnlockNaNNaNUnlock
Upside (Analyst Target)
UnlockNaNNaNUnlock
Fair Value Upside
UnlockNaNNaNUnlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 140.0
(+24.22% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 3.12%
Dividend Yield
6.12%
Industry Median 1.61%
Annualized payout
6.90
Paid unevenly
5-Years Growth
+21.06%
Growth Streak

Earnings

Latest Release
Oct 22, 2025
EPS / Forecast
0.65 / 0.76
Revenue / Forecast
326.64M / 347.50M
EPS Revisions
Last 90 days

BIOGb Income Statement

People Also Watch

105.500
TLXGn
-0.38%
47.560
ITPG
+2.06%
96.80
ACADE
+2.98%

FAQ

What Is the BioGaia B (BIOGb) Stock Price Today?

The BioGaia B stock price today is 112.7

What Stock Exchange Does BioGaia B Trade On?

BioGaia B is listed and trades on the Stockholm Stock Exchange stock exchange.

What Is the Stock Symbol for BioGaia B?

The stock symbol for BioGaia B is "BIOGb."

Does BioGaia B Pay Dividends? What’s The Current Dividend Yield?

The BioGaia B dividend yield is 6.12%.

What Is the BioGaia B Market Cap?

As of today, BioGaia B market cap is 11.40B.

What Is BioGaia B's Earnings Per Share (TTM)?

The BioGaia B EPS (TTM) is 3.12.

When Is the Next BioGaia B Earnings Date?

BioGaia B will release its next earnings report on Feb 12, 2026.

From a Technical Analysis Perspective, Is BIOGb a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has BioGaia B Stock Split?

BioGaia B has split 1 times.

How Many Employees Does BioGaia B Have?

BioGaia B has 238 employees.

What is the current trading status of BioGaia B (BIOGb)?

As of Jan 23, 2026, BioGaia B (BIOGb) is trading at a price of 112.7, with a previous close of 108.0. The stock has fluctuated within a day range of 108.7 to 113.5, while its 52-week range spans from 93.2 to 139.7.

What Is BioGaia B (BIOGb) Price Target According to Analysts?

The average 12-month price target for BioGaia B is SEK140.0, with a high estimate of SEK140 and a low estimate of SEK140. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +24.22% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.